Lisata Therapeutics Inc. - Asset Resilience Ratio

Latest as of September 2025: 0.00%

Lisata Therapeutics Inc. (LSTA) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check LSTA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$21.76 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2024)

This chart shows how Lisata Therapeutics Inc.'s Asset Resilience Ratio has changed over time. See Lisata Therapeutics Inc. net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Lisata Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lisata Therapeutics Inc. market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Lisata Therapeutics Inc. maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Lisata Therapeutics Inc. Industry Peers by Asset Resilience Ratio

Compare Lisata Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Lisata Therapeutics Inc. (1999–2024)

The table below shows the annual Asset Resilience Ratio data for Lisata Therapeutics Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	42.96%	$15.04 Million	$35.00 Million	-8.13pp
2023-12-31	51.09%	$27.94 Million	$54.69 Million	+0.33pp
2022-12-31	50.76%	$37.07 Million	$73.03 Million	-21.73pp
2021-12-31	72.49%	$70.32 Million	$97.01 Million	+22.33pp
2020-12-31	50.17%	$18.06 Million	$36.00 Million	+9.20pp
2019-12-31	40.97%	$11.12 Million	$27.15 Million	-32.50pp
2018-12-31	73.47%	$32.75 Million	$44.58 Million	+32.58pp
2017-12-31	40.89%	$25.92 Million	$63.38 Million	+35.29pp
2014-12-31	5.61%	$7.08 Million	$126.28 Million	+5.61pp
2011-12-31	0.00%	$559.00	$155.33 Million	+0.00pp
2010-12-31	0.00%	$512.00	$143.02 Million	-81.87pp
2001-12-31	81.87%	$1.50 Million	$1.84 Million	+30.41pp
2000-12-31	51.46%	$2.38 Million	$4.62 Million	-1.41pp
1999-12-31	52.86%	$2.73 Million	$5.17 Million	--

pp = percentage points

About Lisata Therapeutics Inc.

NASDAQ:LSTA USA Biotechnology

Market Cap

$31.05 Million

Market Cap Rank

#23703 Global

#5076 in USA

Share Price

$3.52

Change (1 day)

+0.86%

52-Week Range

$1.86 - $5.04

All Time High

$205.50